💡 Curious about the latest advancements in pain management?
Vertex Pharmaceuticals’ new non-opioid medication, **Journavx**, has made headlines as it’s included in UnitedHealth’s Optum Rx formularies, albeit at a higher Tier 3 cost. While Journavx could revolutionize treatment for acute pain and combat the opioid crisis, its steep price may pose hurdles for patient access.
Explore the implications for healthcare spending and market dynamics by diving into the full article.
#SyenzaNews #pharmaceuticals #HealthEconomics